NASDAQ:ESPR

Esperion Therapeutics Stock Predictions

Healthcare > Drug Manufacturers - Specialty & Generic

Buy ESPR

*Your capital is at risk

$3.14

+0 (+0%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

ESPR Prediction Chart

ESPR Predictions History

Latest community submissions for ESPR.

Predictor	Target Session	Target Price	Result	Direction	Accuracy
NameNotImportant Pro	Apr 29, 2019	$45.53 +5.37%	$43.21	X	94.63%
joe.nappi.4471	Mar 20, 2017	$7.59 -81.59%	$41.22	X	18.40%
JS Pro	Mar 20, 2017	$22.88 -44.49%	$41.22	X	55.50%
Uday.V.4287	Mar 20, 2017	$26.00 -36.92%	$41.22	X	63.10%

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ESPR with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT ESPERION THERAPEUTICS

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration a...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by